Elsevier, a global leader in research publishing and information analytics, announced today the global expansion of their new MedReprints service.

The expansion, which extends the growing digital and print-on-demand service to customers globally, is in direct response to an increasing need from Elsevier clients, especially pharmaceutical and healthcare companies and their agencies. The announcement follows a successful pilot program targeting those industries. MedReprints will now supply printed and electronic copies of the latest research to health and pharma companies across all major markets.

MedReprints accelerates and streamlines the reprint and ePrint order process by providing an automated online portal for corporate medical and marketing departments to order reprints of both Elsevier and non-Elsevier published content. Customers around the world can now quickly order and access credible and quality peer-reviewed research to use in their educational and promotional materials to distribute to their targeted healthcare networks.

Elsevier’s offering affirms its position as a market leader amongst reprint and ePrint providers with enhanced platform features that include:

24/7 access to instant quotes and orders
Access to easy ordering and rapid delivery of all reprints and e-reprints
In-app communications and email alerts on customer delivery status
ScienceDirect and SCOPUS integration for article retrieval

Efficient access to reliable reprint services has been found to benefit the medical and research community. More than 80% of physicians read medical articles in reprint format, whilst 90% of physicians say reprints are useful for their practice and viewed as a reliable source of quality, creditable peer reviewed research.

Customer experience is at the core of Elsevier’s MedReprints service which is supported by a round-the-clock, customer service team that can be contacted directly through the online portal. https://www.medreprints.com/get_in_touch

Darren Webster, Managing Director at Elsevier, said: “The launch of Elsevier’s MedReprints service will ensure the continued sharing of quality research to make meaningful innovation happen faster and go further. It will offer our global customers a seamless, more efficient service to get research shared amongst their audiences to help scientists make discoveries, researchers develop new medicines and healthcare professionals improve patient care.”.

More information about Elsevier’s MedReprints can be found https://www.medreprints.com/ , as well as frequently asked questions https://www.medreprints.com/faqs about the service.

Copyright © acrofan All Right Reserved